Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Huhn

Showing results (81-90 of 138) with videos related to

Pageof 14
Sort By:
Frontiers in Psychiatry|May 8, 2023
Operational definition of precipitated opioid withdrawalKelly E Dunn, H Elizabeth Bird, Cecilia L Bergeria, et al.
The International Journal on Drug Policy|May 31, 2022
Patient perceptions of higher-dose naloxone nasal spray for opioid overdoseJustin C Strickland, Katherine R Marks, Kirsten E Smith, et al.
Anesthesiology|November 13, 2018
Analgesic Effects of Hydromorphone versus Buprenorphine in Buprenorphine-maintained IndividualsAndrew S Huhn, Eric C Strain, George E Bigelow, et al.
Journal of Addiction Medicine|February 11, 2026
Xylazine Exposure and Association With Early Physiological and Withdrawal Symptoms in People With Opioid Use DisorderJustin C Strickland, Cecilia L Bergeria, Andrew S Huhn, et al.
Journal of Addiction Medicine|February 9, 2021
Treatment Disruption and Childcare Responsibility as Risk Factors for Drug and Alcohol Use in Persons in Treatment for Substance Use Disorders During the COVID-19 CrisisAndrew S Huhn, Eric C Strain, Jasmyne Jardot, et al.
Drug and Alcohol Dependence|July 24, 2019
The relationship between pupil diameter and other measures of opioid withdrawal during naloxone precipitated withdrawalCecilia L Bergeria, Andrew S Huhn, D Andrew Tompkins, et al.
The American Journal on Addictions|June 24, 2020
Method for Successfully Inducting Individuals Who Use Illicit Fentanyl Onto Buprenorphine/NaloxoneDenis Antoine, Andrew S Huhn, Eric C Strain, et al.
Journal of Addiction Medicine|February 5, 2024
Intersectional Risk and the Significant Gap in Care for Persons With Co-occurring Chronic Pain and Opioid WithdrawalOrrin D Ware, Andrew S Huhn, Jennifer D Ellis, et al.
Experimental and Clinical Psychopharmacology|March 10, 2022
A double-blind, randomized, placebo-controlled, pilot clinical trial examining buspirone as an adjunctive medication during buprenorphine-assisted supervised opioid withdrawalCecilia L Bergeria, Hongjun Tan, Denis Antoine, et al.
Drug and Alcohol Dependence|June 6, 2022
Patient-reported sleep outcomes in randomized-controlled trials in persons with substance use disorders: A systematic reviewAndrew S Huhn, Jennifer D Ellis, Kelly E Dunn, et al.
Pageof 14

Showing results (81-90 of 138) with videos related to

Sort By:
Pageof 14
Frontiers in Psychiatry|May 8, 2023
Operational definition of precipitated opioid withdrawalKelly E Dunn, H Elizabeth Bird, Cecilia L Bergeria, et al.
The International Journal on Drug Policy|May 31, 2022
Patient perceptions of higher-dose naloxone nasal spray for opioid overdoseJustin C Strickland, Katherine R Marks, Kirsten E Smith, et al.
Anesthesiology|November 13, 2018
Analgesic Effects of Hydromorphone versus Buprenorphine in Buprenorphine-maintained IndividualsAndrew S Huhn, Eric C Strain, George E Bigelow, et al.
Journal of Addiction Medicine|February 11, 2026
Xylazine Exposure and Association With Early Physiological and Withdrawal Symptoms in People With Opioid Use DisorderJustin C Strickland, Cecilia L Bergeria, Andrew S Huhn, et al.
Journal of Addiction Medicine|February 9, 2021
Treatment Disruption and Childcare Responsibility as Risk Factors for Drug and Alcohol Use in Persons in Treatment for Substance Use Disorders During the COVID-19 CrisisAndrew S Huhn, Eric C Strain, Jasmyne Jardot, et al.
Drug and Alcohol Dependence|July 24, 2019
The relationship between pupil diameter and other measures of opioid withdrawal during naloxone precipitated withdrawalCecilia L Bergeria, Andrew S Huhn, D Andrew Tompkins, et al.
The American Journal on Addictions|June 24, 2020
Method for Successfully Inducting Individuals Who Use Illicit Fentanyl Onto Buprenorphine/NaloxoneDenis Antoine, Andrew S Huhn, Eric C Strain, et al.
Journal of Addiction Medicine|February 5, 2024
Intersectional Risk and the Significant Gap in Care for Persons With Co-occurring Chronic Pain and Opioid WithdrawalOrrin D Ware, Andrew S Huhn, Jennifer D Ellis, et al.
Experimental and Clinical Psychopharmacology|March 10, 2022
A double-blind, randomized, placebo-controlled, pilot clinical trial examining buspirone as an adjunctive medication during buprenorphine-assisted supervised opioid withdrawalCecilia L Bergeria, Hongjun Tan, Denis Antoine, et al.
Drug and Alcohol Dependence|June 6, 2022
Patient-reported sleep outcomes in randomized-controlled trials in persons with substance use disorders: A systematic reviewAndrew S Huhn, Jennifer D Ellis, Kelly E Dunn, et al.
Pageof 14